Quincy Bioscience is a biotechnology company dedicated to the discovery, development, and commercialization of innovative technologies aimed at supporting cognitive function and addressing health challenges associated with aging. The company's flagship product, Prevagen, is a top-selling memory supplement in chain drug stores across the United States, according to Nielsen data. Prevagen's unique formulation includes the patented ingredient apoaequorin, which is designed to support brain cells and cognitive health during normal aging.

Quincy Bioscience primarily serves consumers who are looking to maintain or improve their cognitive health, particularly those experiencing age-related memory issues. The company operates within the health and wellness market, focusing on dietary supplements that promote brain health.

The business model of Quincy Bioscience revolves around the research, development, and sale of its proprietary supplements. Revenue is generated through direct sales to consumers via their website, as well as through distribution in retail chain drug stores across the country. The company emphasizes innovation and scientific research to maintain its competitive edge and drive growth.

Keywords: cognitive health, memory support, biotechnology, apoaequorin, aging, brain cells, dietary supplements, Prevagen, innovation, research.